You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA2 Syndrome

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

No Evidence of Disease, BRCA1 Syndrome, BRCA2 Syndrome Trial in Duarte, Los Angeles, Sylmar (questionnaire administration,

Active, not recruiting
  • No Evidence of Disease
  • +4 more
  • questionnaire administration
  • +3 more
  • Duarte, California
  • +2 more
Mar 17, 2022

Registry of Subjects at Risk of Pancreatic Cancer

Recruiting
  • Familial Pancreatic Cancer
  • +6 more
  • MRCP
  • Endoultrasonography
  • Rozzano, Milan, Italy
  • +3 more
Jan 12, 2023

Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2

Recruiting
  • Hereditary Breast and Ovarian Cancer
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Jun 3, 2022

    Hereditary Breast and Ovarian Cancer Trial in Cologne, Kiel, Munich (Structured exercise training plus mediterranean diet)

    Active, not recruiting
    • Hereditary Breast and Ovarian Cancer
    • Structured exercise training plus mediterranean diet
    • Cologne, Germany
    • +2 more
    Oct 25, 2022

    Breast & Ovarian Cancer Risk Detection

    Recruiting
    • Adnexal Mass
    • +3 more
    • OVA360
    • Austin, Texas
      Silvana Franco
    Jul 20, 2022

    The Pancreas Interception Center for Early Detection,

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +12 more
    • Data collection
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 11, 2023

    ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

    Recruiting
    • ARID1A Gene Mutation
    • +15 more
    • Scottsdale, Arizona
    • +4 more
    Dec 13, 2022

    Hereditary Breast and Ovarian Cancer Trial in Germany (Structured exercise training plus mediterranean diet)

    Recruiting
    • Hereditary Breast and Ovarian Cancer
    • Structured exercise training plus mediterranean diet
    • Berlin, Germany
    • +18 more
    Oct 25, 2022

    Prostatic Tumor, Prostate Cancer, BRCA2 Mutation Trial in Boston (Prostate cancer screening)

    Recruiting
    • Prostatic Neoplasm
    • +7 more
    • Prostate cancer screening
    • Boston, Massachusetts
      Massachusetts General Hospital
    Nov 30, 2021

    BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome, Breast Ductal Carcinoma In Situ, Hematopoietic and Lymphoid

    Recruiting
    • BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome
    • +5 more
    • Biospecimen Collection
    • +3 more
    • Portland, Oregon
    • +1 more
    Feb 9, 2022

    Deleterious BARD1 Gene Mutation, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation Trial in United States

    Active, not recruiting
    • Deleterious BARD1 Gene Mutation
    • +13 more
    • Laboratory Biomarker Analysis
    • +4 more
    • Chicago, Illinois
    • +8 more
    Feb 25, 2022

    Ultra-rapid BRCA1/2 Status Screening Test in Theranostic

    Not yet recruiting
    • Breast Cancer
    • Questionnaires
    • Communication of the results of the BRCA1/2 ultra rapid test
    • (no location specified)
    Oct 26, 2023

    Germline Variant Carriers With BRCA1 or BRCA2

    Recruiting
    • BRCA1 and/or BRCA2 Variant Carriers
    • +3 more
      • Okayama, Japan
        Okayama University
      Dec 25, 2022

      Breast Cancer, Genetic Disease, BRCA2 Mutation Trial (blood sample for BRCA2 mutation detection)

      Not yet recruiting
      • Breast Cancer
      • +2 more
      • blood sample for BRCA2 mutation detection
      • (no location specified)
      Jun 1, 2023

      Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

      Recruiting
      • Pancreatic Adenocarcinoma Metastatic
      • +14 more
      • Boston, Massachusetts
      • +1 more
      Dec 6, 2022

      Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

      Not yet recruiting
      • Pancreatic Acinar Cell Carcinoma
      • +6 more
      • Nab paclitaxel
      • +5 more
      • (no location specified)
      Oct 30, 2023

      BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

      Active, not recruiting
      Has Results
      • BRCA1 Gene Mutation
      • +5 more
      • Durvalumab
      • +3 more
      • Buffalo, New York
      • +1 more
      Jan 20, 2023

      Cascade Testing in Families With Newly Diagnosed Hereditary

      Recruiting
      • BRCA-Mutated Ovarian Carcinoma
      • +7 more
      • CASCADE genetic screening
      • New York, New York
        NYU Langone Health
      Apr 30, 2021

      Breast Cancer Trial in New York (core needle biopsy, blood draw)

      Recruiting
      • Breast Cancer
      • core needle biopsy
      • blood draw
      • New York, New York
        Memorial Sloan Kettering Cancer Center (All Protocol Activities)
      Nov 9, 2023

      Mesothelioma, Malignant Mesothelioma (MM), Early-stage Mesothelioma Trial run by the National Cancer Institute (NCI)

      Not yet recruiting
      • Mesothelioma
      • +5 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 1, 2023

      Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,

      Not yet recruiting
      • Prostate Adenocarcinoma
      • +2 more
      • Biospecimen Collection
      • +6 more
      • (no location specified)
      Mar 28, 2023

      PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

      Not yet recruiting
      • BRCA Mutation
      • +2 more
      • Germinal BRCA
      • (no location specified)
      Mar 3, 2023

      Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

      Not yet recruiting
      • Breast Cancer
      • +7 more
      • (no location specified)
      Sep 26, 2023

      Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

      Not yet recruiting
      • Metastatic Solid Tumor
      • +4 more
      • San Francisco, California
        University of California, San Francisco
      Jan 12, 2023

      l, Laboratory and Epidemiologic Characterization of Individuals

      Completed
      • Familial Ovarian Cancer
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Dec 31, 2022